Tag Archives: pregnancy

Introduction Pregnancy does not show any specific predisposition to pericardial diseases. The more common form of pericardial involvement in pregnancy is a benign mild pericardial effusion, the incidence of which increases with duration of pregnancy reaching about 40% by the third trimester, resolving uneventfully after delivery.1 Larger effusions should raise clinical concern for an infection, autoimmune disorder or malignancy, which occur sporadically in pregnancy. We report the case of a 34-year-old term pregnant woman who presented with a massive pericardial effusion with cardiac tamponade. Case A 34-year-old woman presented to the emerge

European Society of Cardiology congress 2018, held in Munich Professor Jolien Roos-Hesselink, said: “Pregnancy is safe for most women with heart disease but for some it is too risky. Our study shows that fewer women with heart disease die or have heart failure during pregnancy than 10 years ago. However, nearly one in 10 women with pulmonary arterial hypertension died during pregnancy or early post-partum.” She added that pre-pregnancy counselling is crucial to identify women who should be advised against pregnancy, for instance in those with severe valvular heart disease, and to discuss the risks, options and to initiate timely treatment

European Society of Cardiology congress 2018, held in Munich Other news from the European Society of Cardiology Congress 2018 Not all HDL cholesterol is cardioprotective COMMANDER HF: rivaroxaban in heart failure… …and in VTE in the MARINER trial Is it safe for women with heart disease to become pregnant? Several new guidelines from the ESC were announced at the meeting: ESC guidelines on the management of cardiovascular diseases during pregnancy, first published in 2011, have been updated with a second edition in 2018 2018 ESC/EACTS (European Association for Cardio-Thoracic Surgery) guidelines on myocardial revascularisation 2018 ES

Introduction Peri-partum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy with symptoms and signs of heart failure, secondary to disorders of ventricular systolic function, in late pregnancy or postpartum, where no other cause of heart failure is found. PPCM is one of the main causes of maternal death worldwide. Data in the US show the incidence of PPCM reaches one in 2,500 to 4,000 pregnancies, while data on the incidence in Indonesia are still unknown. Data from the 2012 IDHS (Indonesian Demographic and Health Survey) showed heart failure, including PPCM, as the cause of a high maternal mortality rate in Indonesia reaching 228 per 100,

Current guidelines state that blood pressure should be monitored routinely at antenatal appointments, with increased frequency in high-risk pregnancy and if problems develop.4 Self-monitoring enables women to monitor their own blood pressure between routine appointments, potentially identifying hypertension earlier and aiding management once it is established.5 Self-monitoring is becoming increasingly popular among patients and healthcare professionals. One US study found that 60% of women with hypertension in pregnancy were self-monitoring.6 However, few studies have assessed its safety and effectiveness and whether it will have any effect o

Introduction Women with cardiac disease are at increased risk during pregnancy due, in part, to the volume loading and increased cardiac output associated with normal pregnancy. Any haemodynamic changes are magnified in the case of a multiple pregnancy. It is essential that any woman with acquired or congenital heart disease, or those at increased risk, e.g. an adult survivor of childhood cancer who may have subclinical left ventricular dysfunction, be seen for pre-pregnancy counselling to quantify their risk and optimise their cardiac state prior to conception. Deaths from cardiac disease in pregnancy are increasing, and cardiac disease rem

Background Heart disease is the leading cause of death in pregnant women and, despite advances in cardiology, maternal deaths from cardiac disease have increased over the past 20 years.1 Cardiac conditions such as pulmonary hypertension, severe valve disease, cyanotic and complex congenital heart disease carry a high mortality2 and need specialist care.3 It has been recommended that pregnant women with cardiac disease should be managed in tertiary centres,4 and many cardiologists caring for pregnant women have a background in congenital heart disease, necessary for the management of complex congenital heart disease. Previously reported series

No content available

No content available

No content available